Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative analysis of Altebrel versus Enbrel in rheumatoid arthritis
IRCT201206266302N3Phase 3Completed
- Sponsor
- AryoGen Biopharma
- Start
- Oct 2012
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of Altebrel and etanercept in rheumatoid arthritis (RA) (2 arms), sponsored by AryoGen Biopharma. Started Oct 2012; status: completed.
02
Drugs
Altebreletanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on IRCT201206266302N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201206266302N3.